معرفی
Pascal Campagne is a researcher at the Institut Pasteur in Paris, affiliated with the Bioinformatics and Biostatistics HUB (C3BI-Hub) and the INCEPTION convergence institute. His work focuses on biostatistics, statistical experimental design, and the analysis of genetic and microbiome data.
Research Interests: His primary research areas include biostatistics, statistical experiment design, genomics, population genetics, and microbiome analysis. He applies these to infectious diseases such as malaria and SARS-CoV-2, as well as immunological conditions like multiple sclerosis. He is particularly interested in improving biological experimental design through statistical rigor.
Publications and Research Trends: His recent publications (2020–2025) reflect a strong interdisciplinary focus, combining computational biology with infectious disease epidemiology and immunology. Key themes include artemisinin resistance in Plasmodium falciparum, host immune responses in tuberculosis and SARS-CoV-2, and statistical tools for microbiome analysis. His work often involves large-scale genomic and phenotypic datasets, with applications in public health and drug development.
Scientific Contributions:
- Principal Investigator of SHADE (SHiny Application for Designing Experiments), a tool to support biologists in refining experimental designs and performing power analysis.
- Contributor to SHAMAN, a web platform for user-friendly metataxonomic analysis of microbiome data.
- Active collaborator on projects related to malaria resistance, SARS-CoV-2 transmission, and multiple sclerosis immunology.
Advising and Grants: While no formal students are listed, he leads the SHADE project and contributes to PhD training programs at Institut Pasteur. He has participated in research funded by major institutions including ANRS, Vaccine Research Institute, Labex IBEID, ANR/FRM, IDISCOVR, and the Fondation pour la Recherche Médicale.
Labs and Teams: He is a core member of the Bioinformatics and Biostatistics HUB at Institut Pasteur, working within the C3BI team. He collaborates across multiple interdisciplinary projects, including those on malaria evolution, immune profiling, and microfluidic screening for drug discovery.
